This information is provided for educational purposes only.  Reader retains full responsibility for the use of the information contained herein.

Lawmakers on the federal level are debating passing the proposed Rohrabacher-Blumenauer amendment, a law that would not only restrict federal government enforcement of marijuana laws, but would also benefit the black market by allowing them to seek legal cover for drug trafficking.  States with legal recreational marijuana have already shown that criminals often use legal marijuana as a cover for other illegal activities.

Colorado officials recently indicted 62 people and 12 businesses for their involvement in an interstate drug trafficking ring that used the cover of medical marijuana distributors.  The same officials report that cartel activity has only increased in the state following marijuana legalization.  In addition, Colorado marijuana enforcement officers and regulators in the Colorado Department of Revenue have also been implicated in black market operations pertaining to marijuana.

Oregon is no different, with a leaked Oregon State Police report revealing that the state produces much more marijuana than the state market could consume.  An estimated 70% of Oregon marijuana transactions are on the black market, and there is a high rate of diversion for marijuana out of state.

Passing the Rohrabacher-Blumenauer amendment would allow states to continue to have medical and/or recreational marijuana, yes, but at what cost?  Federal official would be barred from helping track and take down black market drug shipments, a business that does not respect state lines.

So, what is the answer?  Urge the FDA to do more research into marijuana and it’s possible medicinal uses.  If we’re going to be using marijuana as a medical drug, it should be regulated in studied in the same way that other drugs need to be.  Ask yourself, are we moving in the right direction in regards to marijuana?

Click here to read more.

(C) 2017 The Current Consulting Group, LLC – No portion of this article may be reproduced, retransmitted, posted on a website or used in any manner without the written consent of the Current Consulting Group, LLC. When permission is granted to reproduce this article in any way full attribution to the author and copyright holder are required.

Leave a comment

Your email address will not be published. Required fields are marked *